Company Merck & Co., Inc. Swiss Exchange

Company Merck & Co., Inc. Swiss Exchange

MRK

US58933Y1055

Pharmaceuticals

Analysts' Consensus

Equities

MRK

US58933Y1055

Pharmaceuticals

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Holdings

Company contact information

Group companies

Sector

Sales per Business

Sales per region

Ratings for Merck & Co., Inc.

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Pharmaceuticals

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Holdings

Company contact information

Group companies

Sector

Sales per Business

Sales per region

Ratings for Merck & Co., Inc.

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Pharmaceuticals

Market Closed - Swiss Exchange Other stock markets 16:36:38 05/12/2022 GMT			5-day change	1st Jan Change
400 ^CHF	+388.82%		-.--%	-.--%

06-13	High-risk health workers can get routine Ebola vaccine, Gavi says	RE
06-13	AbbVie inks immune disorder drug licensing deal with China's FutureGen	RE

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:

- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;

- sale of vaccines (18%);

- sale of animal health products (9.4%);

- other (2.9%).

Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).

USD in Million	2022	Weight	2023	Weight	Delta
Pharmaceutical 89.1 %	52,005	87.7 %	53,583	89.1 %	+3.03%
Animal Health 9.4 %	5,550	9.4 %	5,625	9.4 %	+1.35%
Other 1.5 %	1,728	2.9 %	907	1.5 %	-47.51%

USD in Million	2022	Weight	2023	Weight	Delta
United States 47.4 %	27,206	45.9 %	28,480	47.4 %	+4.68%
Europe, Middle East and Africa 22.0 %	14,493	24.4 %	13,254	22.0 %	-8.55%
China 11.3 %	5,191	8.8 %	6,802	11.3 %	+31.03%
Asia Pacific 5.4 %	3,614	6.1 %	3,225	5.4 %	-10.76%
Japan 5.3 %	3,629	6.1 %	3,164	5.3 %	-12.81%
Latin America 5.1 %	2,582	4.4 %	3,086	5.1 %	+19.52%
Other 3.5 %	2,568	4.3 %	2,104	3.5 %	-18.07%

Managers	Title	Age	Since
Robert Davis CEO	Chief Executive Officer	57	31/03/14
Caroline Litchfield DFI	Director of Finance/CFO	55	31/12/89
Dave Williams CTO	Chief Tech/Sci/R&D Officer	55	31/07/20
Joseph Romanelli IRC	Investor Relations Contact	50	31/12/95
Peter Dannenbaum IRC	Investor Relations Contact	-	30/06/17
Andre Musto PRN	Corporate Officer/Principal	-	30/06/14
Brooke Hinkson PRN	Corporate Officer/Principal	-	31/07/15
Carol Bowden PRN	Corporate Officer/Principal	-	31/03/14
Dalton Smart AUD	Comptroller/Controller/Auditor	58	31/10/09
James Matteucci PRN	Corporate Officer/Principal	-	31/12/02

Members of the board	Title	Age	Since
Tom Glocer BRD	Director/Board Member	63	26/11/07
Pamela Craig BRD	Director/Board Member	67	31/08/15
Inge Thulin BRD	Director/Board Member	69	28/02/18
Patricia Russo BRD	Director/Board Member	71	31/08/95
Risa Lavizzo-Mourey BRD	Director/Board Member	69	25/05/20
Robert Davis CEO	Chief Executive Officer	57	31/03/14
Douglas Baker BRD	Director/Board Member	65	23/05/22
Stephen Mayo BRD	Director/Board Member	62	14/03/21
Kathy Warden BRD	Director/Board Member	52	15/03/20
Christine Seidman BRD	Director/Board Member	71	15/03/20

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	3,577,208,962	2,531,418,332 ( 70.77 %)	1,044,402,655 ( 29.20 %)	70.77 %

Name	Equities	%	Valuation
Vanguard Fiduciary Trust Co. 9.605 %	243,269,899	9.605 %	30 540 M CHF
BlackRock Advisors LLC 6.177 %	156,460,386	6.177 %	19 642 M CHF
STATE STREET CORPORATION 4.636 %	117,425,530	4.636 %	14 742 M CHF
Wellington Management Co. LLP 3.409 %	86,348,259	3.409 %	10 840 M CHF
Geode Capital Management LLC 2.227 %	56,411,229	2.227 %	7 082 M CHF
Fidelity Management & Research Co. LLC 2.058 %	52,116,893	2.058 %	6 543 M CHF
BlackRock Life Ltd. 1.703 %	43,121,867	1.703 %	5 414 M CHF
Eaton Vance Management 1.639 %	41,505,855	1.639 %	5 211 M CHF
Merrill Lynch International 1.484 %	37,576,885	1.484 %	4 717 M CHF
T. Rowe Price International Ltd. 1.170 %	29,639,517	1.170 %	3 721 M CHF

Name	Equities	%	Valuation
Caixa DTVM SA 0.001503 %	304,520	0.001503 %	5 M CHF
BB Gestão de Recursos DTVM SA 0.000900 %	182,400	0.000900 %	3 M CHF
Safra Asset Management Ltda. 0.000318 %	64,500	0.000318 %	1 M CHF
Bram Bradesco Asset Management S/A DTVM 0.000205 %	41,594	0.000205 %	651 626 CHF
XP Allocation Asset Management Ltda. 0.000093 %	18,763	0.000093 %	293 948 CHF

Name	Equities	%	Valuation
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD. 10.32%	13,443,693	10.32%	295,909,530 $
ENTRADA THERAPEUTICS, INC. 5.15%	1,739,768	5.15%	26,914,211 $
XILIO THERAPEUTICS, INC. 4.02%	1,483,414	4.02%	1,602,087 $
EVAXION BIOTECH A/S 12.13%	2,297,884	12.13%	843,323 $

Merck & Co., Inc.

126 East Lincoln Avenue

07065, Rahway

+908 740 4000

http://www.merck.com

Name	Category and Sector
MSD Regional Business Support Center GmbH MSD Regional Business Support Center GmbH Miscellaneous Commercial ServicesCommercial Services Part of Merck & Co., Inc., MSD Regional Business Support Center GmbH is a German company that provides management consulting services. The company is based in Munich, Germany. Jutta König has been the CEO of the company since 2021.	Miscellaneous Commercial Services
Merck Holdings, Inc.
MSD International GmbH (Switzerland) MSD International GmbH (Switzerland) Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., MSD International GmbH (Switzerland) is a Swiss company that discovers, develops and markets human and animal health products. The company is located in Switzerland.	Pharmaceuticals: Major
Schering Plough International Finance Co. BV
MSD Human Health Holding BV MSD Human Health Holding BV Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., MSD Human Health Holding BV discovers, develops and markets human and animal health products. The company is based in Oss, Netherlands.	Pharmaceuticals: Major
Merck Sharp & Dohme LLC Merck Sharp & Dohme LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Sharp & Dohme LLC is a pharmaceutical company. The company is based in Kenilworth, NJ.	Pharmaceuticals: Major
Merck Sharp & Dohme Corp. Merck Sharp & Dohme Corp. Pharmaceuticals: MajorHealth Technology Merck Sharp & Dohme Corp. engages in the research, development, and distribution of vaccines, prescription drugs, and animal health products. The company is headquartered in Whitehouse Station, NJ.	Pharmaceuticals: Major
Essex Chemie AG
Merck Sharp & Dohme BV Merck Sharp & Dohme BV Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Sharp & Dohme BV is a Dutch company that manufactures and distributes pharmaceutical products. The company is based in Haarlem, the Netherlands.	Pharmaceuticals: Major
MSD Finance 2 LLC
MSD Animal Health Pension Scheme MSD Animal Health Pension Scheme Investment ManagersFinance Part of Merck & Co., Inc., MSD Animal Health Pension Scheme is a British company. The company is located in the UK.	Investment Managers
Organon (India) Pvt Ltd. Organon (India) Pvt Ltd. Pharmaceuticals: MajorHealth Technology Organon India Pvt Ltd. manufactures and distribution of pharmaceutical preparations. The company is headquartered in Mumbai, India.	Pharmaceuticals: Major
Dashtag Dashtag Financial ConglomeratesFinance Founded in 1906, Dashtag is a part of Organon & Co. and operates an investment holding British company. The company is based in Hoddesdon, UK.	Financial Conglomerates
Merck Sharp & Dohme Manufacturing Unlimited Co.
Merck International Holdings LLC
MSD Sharp & Dohme GmbH MSD Sharp & Dohme GmbH Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., MSD Sharp & Dohme GmbH develops and manufactures pharmaceutical products. The company is based in Haar, Germany. The German company was founded in 1891. Chantal Friebertshäuser has been the CEO of the company since 2007.	Pharmaceuticals: Major
Organon LLC
Intervet India Pvt Ltd.
MSD International Business GmbH
GTS FI BV GTS FI BV Financial ConglomeratesFinance Part of Organon & Co., GTS FI BV is an investment holding Dutch company that provides financing services. The company is located in Netherlands.	Financial Conglomerates
MSD FI BV MSD FI BV Financial ConglomeratesFinance Part of Merck & Co., Inc., MSD FI BV is an investment holding Dutch company. The company is based in Haarlem, Netherlands.	Financial Conglomerates
MSD Pharmaceuticals Pvt Ltd.
MSD Pharmaceuticals Investments 3 (Bermuda) MSD Pharmaceuticals Investments 3 (Bermuda) Financial ConglomeratesFinance Part of Merck & Co., Inc., MSD Pharmaceuticals Investments 3 (Bermuda) provides investment services. The company is located in Bermuda.	Financial Conglomerates
Merck Sharp & Dohme Finance Europe Ltd. Merck Sharp & Dohme Finance Europe Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 1993, Merck Sharp & Dohme Finance Europe Ltd. is a British company that provides business support services. Part of Merck & Co., Inc., the company is based in Hoddesdon, UK.	Miscellaneous Commercial Services
FULFORD (INDIA) LIMITED	Pharmaceuticals: Major

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

129.5 USD

Average target price

142.7 USD

Spread / Average Target

+10.20%

Consensus

Estimates Revisions

Company calendar

	1st Jan change	Capi.
ELI LILLY AND COMPANY	+52.16%	791B
NOVO NORDISK A/S	+40.45%	630B
ABBVIE INC.	+9.29%	298B
ASTRAZENECA PLC	+17.25%	246B
ROCHE HOLDING AG	+0.41%	225B
NOVARTIS AG	+10.22%	218B
AMGEN INC.	+4.59%	160B
PFIZER, INC.	-6.32%	156B
SANOFI	-2.33%	116B

Other Pharmaceuticals

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Other Pharmaceuticals